Taken together, it is remarkable that most FGFR3::TACC3 fusion carcinomas display either a transitional cell-like morphology (including urothelial carcinoma), a squamous cell phenotype (SCC), or combined features of both [10, 11]. This evidence concerns the gene FGFR3 and carcinoma.